Sökning: "epoetin"

Hittade 3 avhandlingar innehållade ordet epoetin.

1. 1. Effects of Hemoglobin Normalization with Epoetin in Chronic Kidney Disease

   Författare :Hans Furuland; Björn Wikström; Torbjörn Linde; Peter Barany; Uppsala universitet; []
   Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Internal medicine; Anemia; blood viscosity; cardiac output; chronic kidney disease; renal dialysis; dialysis adequacy; erythopoietin; heart rate variability; hemoglobin; hemorheology; hypertension; kidney transplantation; Kt V; left ventricular hypertrophy; Quality of Life; Invärtesmedicin; Internal medicine; Invärtesmedicin;

   Sammanfattning : Anemia is common in patients with chronic kidney disease (CDK), contributes to reduced Quality of Life (QoL) and is associated with cardiovascular disease, morbidity and mortality. Epoetin raises hemoglobin (Hb) and increases QoL and physical exercise capacity. LÄS MER

3. 2. Fat mass, adipokines and clinical complications of chronic kidney disease

   Författare :Jonas Axelsson; Karolinska Institutet; Karolinska Institutet; []
   Nyckelord :Chronic kidney disease; end-stage renal disease; insulin resistance; inflammation; cardiovascular disease; adipokines; leptin; epoetin; resistin; visfatin; AHSG; CD163; outcome.;

   Sammanfattning : Patients with chronic kidney disease (CKD), irrespective of initial etiology, have a risk of cardiovascular morbidity (CVD) and mortality that is many-fold higher than that of a similar person without CKD. While traditional risk factors, such as hyperlipidemia, certainly contribute, these factors cannot by themselves explain the burden of CVD. LÄS MER

4. 3. Clinical impact of epoetins in the treatment of anemia with special emphasis on patients with lymphoid malignancies. : dosing, iron supplementation and safety

   Författare :Michael Hedenus; Jack Lindh; Anders Österborg; Robert Hast; Umeå universitet; []
   Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; anemia; cancer; lymphoproliferative malignancies; erythropoietin; intravenous iron; safety; Oncology; Onkologi; Oncology; onkologi;

   Sammanfattning : The aim of this thesis was to determine the relevant dose of arbepoetin-alfa (DA) in patients with lymphoproliferative diseases (LPD) and chemotherapy induced anemia (CIA), to study the clinical impact of intravenous (IV) iron supplementation combined with epoetin beta treatment, to identify factors that might predict hemoglobin (Hb) response to treatment with epoetins and to investigate safety of DA.A dose-finding phase II study was able to assess a reasonable DA dose of 2. LÄS MER